Etoricoxib as a treatment of choice for patients with mutation exhibiting autosomal recessive primary hypertrophic osteoarthropathy: A case report.

We reported a 22-year-old Emirati male with autosomal recessive primary hypertrophic osteoarthropathy caused by a possibly pathogenic homozygous non-synonymous variant in the gene (NM_005630.3: c.289C>T, p.